Specialty Chemicals
All research in Specialty Chemicals — 4 reports.
The world's largest maker of PEEK (a high-performance engineering plastic), Victrex builds metal-replacement specialty polymers sold into aerospace, medical, electronics, and automotive; its leadership position, vertical integration, and Invibio implant-grade medical franchise (~75% gross margin) form a real moat. It is now hitting a structural pricing reset from low-cost Chinese PEEK (roughly half the import price)—volumes are rising but profits are falling, and underlying operating margin has been halved from 28% to 16.5%. Rating Watch: a world-class asset facing structural margin erosion and a likely dividend cut, cheap but not yet safe.
Syensqo is the Belgian specialty-materials company spun off from Solvay, posting €5.762 billion of 2025 sales and a 20.6% EBITDA margin but only 6.2% ROCE, with its portfolio still being reshaped. At €67.65 the stock sits in the middle of fair value, with an ideal buy range of €48–58 and an insufficient margin of safety. Rating Watch: a business with real technology and several quality niche assets, but not yet proven to be a high-return compounder, and not yet cheap enough.
On the Buffett framework, the verdict is Watch. Toray expects roughly JPY 2.585 trillion of FY2026 revenue, yet ROIC is just 4.7% and ROE 4.5%. At about JPY 1,160 (P/B 0.94) the stock looks cheaper than book, but a conservative owner-earnings figure of about JPY 77 billion implies 22x, which is not cheap. Rating Watch: a complex materials group with some excellent assets but a margin of safety that is not yet there at a fair-buy band of JPY 850–950.
A Buffett-framework rating of Watch. Trelleborg is a high-quality engineered-polymer platform with solid cash flow and a sturdy balance sheet, yet ROCE of roughly 12% sits below target; at about SEK 399 it trades at 26-28x owner earnings, with a fair entry of SEK 260-310 and an insufficient margin of safety. Rating Watch: a quality industrial worth owning, but not at today's price.